STEAP1 and Ewing sarcoma: STEAP1, STEAP2, and STEAP4 have been evaluated as possible diagnostic and prognostic biomarkers in glioblastoma, breast cancer, Ewing sarcoma, lung cancer, and PCa [50,51,52,53,54].